Author:
Bai Rui-na,Gu Feng,Che Qian-zi,Zhang Xuan,Cai Ya-jie,Xi Rui-xi,Zhao Yang,Guo Ming,Dong Guo-ju,Gao Zhu-ye,Fu Chang-geng,Wang Pei-li,Du Jian-peng,Zhang Da-wu,Duan Wen-hui,Li Li-zhi,Yang Qiao-ning,Shi Da-zhuo
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, et al. Oral antiplatelet therapy after acute coronary syndrome: a review. JAMA 2021;325:1545–1555.
2. Kang J, Hwang D, Park KW, Han JK, Yang HM, Kang HJ, et al. Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial. Euro Intervention 2024;20:750–759.
3. Ma XT, Shao QY, Li QX, Yang ZQ, Han KN, Liang J, et al. Nutritional risk index improves the GRACE score prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Front Cardiovasc Med 2021;8:773200.
4. Bergmark BA, Bhatt DL, Steg PG, Budaj A, Storey RF, Gurmu Y, et al. Long-term ticagrelor in patients with prior coronary stenting in the PEGASUS-TIMI 54 trial. J Am Heart Assoc 2021;10:e020446.
5. Xie Q, Gong L, Huang F, Cao M, Liu Y, Yuan H, et al. A rapid and accurate 1HNMR method for the identification and quantification of major constituents in Qishen Yiqi Dripping Pill. J AOAC Int 2021;104:506–514.